PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33987439-0	2021	BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.	Sorafenib	64-73	AKT serine/threonine kinase 1	Homo sapiens	93-96	
33987439-9	2021	SFB + BEZ inhibited the activation of the PI3K/AKT/mTOR pathway caused by sorafenib.	Sorafenib	74-83	AKT serine/threonine kinase 1	Homo sapiens	47-50	
33987439-13	2021	We concluded that BEZ235 enhanced the sensitivity of sorafenib through suppressing the PI3K/AKT/mTOR pathway and inducing autophagy.	Sorafenib	53-62	AKT serine/threonine kinase 1	Homo sapiens	92-95